Sinocare Inc. (SHE:300298)

China · Delayed Price · Currency is CNY

15.64

+0.42 (2.76%)

Jul 15, 2026, 11:54 AM CST

-29.17% (1Y)

Market Cap	8.32B -32.2%
Revenue (ttm)	4.86B +8.6%
Net Income	118.22M -62.8%
EPS	0.22 -62.3%
Shares Out	546.53M
PE Ratio	70.43
Forward PE	20.50
Dividend	0.22 (1.45%)
Ex-Dividend Date	Jun 13, 2025

Volume	8,405,076
Open	14.22
Previous Close	15.22
Day's Range	14.22 - 15.68
52-Week Range	13.37 - 23.96
Beta	-0.08
Analysts	Strong Buy
Price Target	22.84 (+46.04%)
Earnings Date	Aug 4, 2026

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products. The company was founded in 2002 and is based in Changsha, the Pe... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2002

Employees 5,010

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300298

Full Company Profile

Financial Performance

In 2025, Sinocare's revenue was 4.66 billion, an increase of 4.87% compared to the previous year's 4.44 billion. Earnings were 92.65 million, a decrease of -71.61%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 300298 stock is "Strong Buy." The 12-month stock price target is ¥22.84, which is an increase of 46.04% from the latest price.

Price Target

¥22.84

(46.04% upside)

Analyst Consensus: Strong Buy

Stock Forecasts